nadp has been researched along with Angina Pectoris, Variant in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawano, H; Kugiyama, K; Miyamoto, S; Miyao, Y; Ogawa, H; Sakamoto, T; Soejima, H; Sugiyama, S; Yasue, H; Yoshimura, M | 1 |
1 trial(s) available for nadp and Angina Pectoris, Variant
| Article | Year |
|---|---|
Glutathione attenuates coronary constriction to acetylcholine in patients with coronary spastic angina.
Topics: Acetylcholine; Adult; Aged; Angina Pectoris, Variant; Antioxidants; Blood Pressure; Coronary Angiography; Coronary Circulation; Electrocardiography; Female; Glutathione; Heart Rate; Humans; Male; Middle Aged; NADP; Nitroglycerin; Thiobarbituric Acid Reactive Substances; Vasoconstrictor Agents; Vasodilator Agents | 2001 |